Funder: National Institutes of Health
Due Dates: June 5, 2025 (New) | July 5, 2025 (Renewal/Resubmission) | October 5, 2025 (New) | November 5, 2025 (Renewal/Resubmission) | February 5, 2026 (New) | March 5, 2026 (Renewal/Resubmission) | June 5, 2026 (New) | July 5, 2026 (Renewal/Resubmission) | October 5, 2026 (New) | November 5, 2026 (Renewal/Resubmission)
Funding Amounts: No budget cap; budgets must reflect actual project needs. Maximum project period: 5 years.
Summary: Supports high-risk, multi-center therapeutic clinical trials with potential to change clinical practice or public health in NIDDK mission areas; planning activities must be completed prior to application.
Key Information: Only high-risk, therapeutic multi-center trials are eligible; mechanistic or low-risk trials, animal/in vitro studies, and applications from non-U.S. organizations are not allowed.